Search research articles
Contact Us
Filters
Showing results (91-100 of 101) with videos related to
Page
of 11
Sort By:
Bioactive Materials
|
March 30, 2026
Heme cascade-triggered nanovesicles for myocardial ischemic core delivery
Hui Chen, Ying Yang, Mirenuer Aikebaier, et al.
Diabetology & Metabolic Syndrome
|
August 8, 2024
Nonlinear association between the triglyceride-glucose index and diabetes mellitus in overweight and obese individuals: a cross-sectional retrospective analysis
Yongbing Sun, Yuang Gu, Yang Zhou, et al.
Journal of Hypertension
|
June 26, 2024
Association between liver fat level and risk of hypertension: evidence from a Chinese health examination dataset
Yongbing Sun, Xin Qi, Xuan Wang, et al.
Frontiers in Psychiatry
|
January 23, 2026
Disrupted gray matter structural covariance networks in chronic insomnia disorder
Zhonglin Li, Yu Shen, Jiao Liu, et al.
Hepatology International
|
August 25, 2025
Efficacy and safety of atezolizumab and bevacizumab with or without TACE as first-line therapy for unresectable HCC: a multicenter cohort study
Ningning Zhang, Kaipeng Liu, Yuexi Yu, et al.
Acta Pharmaceutica Sinica. B
|
January 14, 2025
Comparison of Jinzhen oral liquid and ambroxol hydrochloride and clenbuterol hydrochloride oral solution in the treatment of acute bronchitis in children: A multicenter, non-inferiority, prospective, randomized controlled trial
Qinhua Fan, Chongming Wu, Yawei Du, et al.
Science (New York, N.Y.)
|
June 2, 2022
Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy
Stanley C Xie, Riley D Metcalfe, Elyse Dunn, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 22, 2021
Design of proteasome inhibitors with oral efficacy in vivo against <i>Plasmodium falciparum</i> and selectivity over the human proteasome
Stanley C Xie, Riley D Metcalfe, Hirotake Mizutani, et al.
Plos Pathogens
|
December 9, 2024
A potent and selective reaction hijacking inhibitor of Plasmodium falciparum tyrosine tRNA synthetase exhibits single dose oral efficacy in vivo
Stanley C Xie, Chia-Wei Tai, Craig J Morton, et al.
Research Square
|
August 7, 2023
Reaction hijacking inhibition of <i>Plasmodium falciparum</i> asparagine tRNA synthetase
Stanley C Xie, Yinuo Wang, Craig J Morton, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 101) with videos related to
Sort By:
Page
of 11
Bioactive Materials
|
March 30, 2026
Heme cascade-triggered nanovesicles for myocardial ischemic core delivery
Hui Chen, Ying Yang, Mirenuer Aikebaier, et al.
Diabetology & Metabolic Syndrome
|
August 8, 2024
Nonlinear association between the triglyceride-glucose index and diabetes mellitus in overweight and obese individuals: a cross-sectional retrospective analysis
Yongbing Sun, Yuang Gu, Yang Zhou, et al.
Journal of Hypertension
|
June 26, 2024
Association between liver fat level and risk of hypertension: evidence from a Chinese health examination dataset
Yongbing Sun, Xin Qi, Xuan Wang, et al.
Frontiers in Psychiatry
|
January 23, 2026
Disrupted gray matter structural covariance networks in chronic insomnia disorder
Zhonglin Li, Yu Shen, Jiao Liu, et al.
Hepatology International
|
August 25, 2025
Efficacy and safety of atezolizumab and bevacizumab with or without TACE as first-line therapy for unresectable HCC: a multicenter cohort study
Ningning Zhang, Kaipeng Liu, Yuexi Yu, et al.
Acta Pharmaceutica Sinica. B
|
January 14, 2025
Comparison of Jinzhen oral liquid and ambroxol hydrochloride and clenbuterol hydrochloride oral solution in the treatment of acute bronchitis in children: A multicenter, non-inferiority, prospective, randomized controlled trial
Qinhua Fan, Chongming Wu, Yawei Du, et al.
Science (New York, N.Y.)
|
June 2, 2022
Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy
Stanley C Xie, Riley D Metcalfe, Elyse Dunn, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 22, 2021
Design of proteasome inhibitors with oral efficacy in vivo against <i>Plasmodium falciparum</i> and selectivity over the human proteasome
Stanley C Xie, Riley D Metcalfe, Hirotake Mizutani, et al.
Plos Pathogens
|
December 9, 2024
A potent and selective reaction hijacking inhibitor of Plasmodium falciparum tyrosine tRNA synthetase exhibits single dose oral efficacy in vivo
Stanley C Xie, Chia-Wei Tai, Craig J Morton, et al.
Research Square
|
August 7, 2023
Reaction hijacking inhibition of <i>Plasmodium falciparum</i> asparagine tRNA synthetase
Stanley C Xie, Yinuo Wang, Craig J Morton, et al.
Page
of 11